The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sodium Valproate Market Research Report 2024
Synopsis
Valproate (VPA), and its valproic acid, sodium valproate, and valproate semisodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures.
The global Sodium Valproate market was valued at US$ 167 million in 2023 and is anticipated to reach US$ 252.5 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
North American market for Sodium Valproate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sodium Valproate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sodium Valproate include Sanofi, AbbVie, Athenex, Fresenius Kabi, Hikma Farmaceutica, Desitin Pharmaceuticals, Wockhardt and Zentiva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sodium Valproate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sodium Valproate.
Report Scope
The Sodium Valproate market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sodium Valproate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sodium Valproate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
AbbVie
Athenex
Fresenius Kabi
Hikma Farmaceutica
Desitin Pharmaceuticals
Wockhardt
Zentiva
Segment by Type
Injection
Tablet
Liquid
Segment by Application
Epilepsy
Migraines
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sodium Valproate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sodium Valproate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Valproate (VPA), and its valproic acid, sodium valproate, and valproate semisodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures.
The global Sodium Valproate market was valued at US$ 167 million in 2023 and is anticipated to reach US$ 252.5 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
North American market for Sodium Valproate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sodium Valproate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sodium Valproate include Sanofi, AbbVie, Athenex, Fresenius Kabi, Hikma Farmaceutica, Desitin Pharmaceuticals, Wockhardt and Zentiva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sodium Valproate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sodium Valproate.
Report Scope
The Sodium Valproate market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sodium Valproate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sodium Valproate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
AbbVie
Athenex
Fresenius Kabi
Hikma Farmaceutica
Desitin Pharmaceuticals
Wockhardt
Zentiva
Segment by Type
Injection
Tablet
Liquid
Segment by Application
Epilepsy
Migraines
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sodium Valproate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sodium Valproate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Sodium Valproate Market Overview
1.1 Product Overview and Scope of Sodium Valproate
1.2 Sodium Valproate Segment by Type
1.2.1 Global Sodium Valproate Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Tablet
1.2.4 Liquid
1.3 Sodium Valproate Segment by Application
1.3.1 Global Sodium Valproate Market Value by Application: (2024-2030)
1.3.2 Epilepsy
1.3.3 Migraines
1.3.4 Others
1.4 Global Sodium Valproate Market Size Estimates and Forecasts
1.4.1 Global Sodium Valproate Revenue 2019-2030
1.4.2 Global Sodium Valproate Sales 2019-2030
1.4.3 Global Sodium Valproate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sodium Valproate Market Competition by Manufacturers
2.1 Global Sodium Valproate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sodium Valproate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sodium Valproate Average Price by Manufacturers (2019-2024)
2.4 Global Sodium Valproate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sodium Valproate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sodium Valproate, Product Type & Application
2.7 Sodium Valproate Market Competitive Situation and Trends
2.7.1 Sodium Valproate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sodium Valproate Players Market Share by Revenue
2.7.3 Global Sodium Valproate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sodium Valproate Retrospective Market Scenario by Region
3.1 Global Sodium Valproate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sodium Valproate Global Sodium Valproate Sales by Region: 2019-2030
3.2.1 Global Sodium Valproate Sales by Region: 2019-2024
3.2.2 Global Sodium Valproate Sales by Region: 2025-2030
3.3 Global Sodium Valproate Global Sodium Valproate Revenue by Region: 2019-2030
3.3.1 Global Sodium Valproate Revenue by Region: 2019-2024
3.3.2 Global Sodium Valproate Revenue by Region: 2025-2030
3.4 North America Sodium Valproate Market Facts & Figures by Country
3.4.1 North America Sodium Valproate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sodium Valproate Sales by Country (2019-2030)
3.4.3 North America Sodium Valproate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sodium Valproate Market Facts & Figures by Country
3.5.1 Europe Sodium Valproate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sodium Valproate Sales by Country (2019-2030)
3.5.3 Europe Sodium Valproate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sodium Valproate Market Facts & Figures by Country
3.6.1 Asia Pacific Sodium Valproate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sodium Valproate Sales by Country (2019-2030)
3.6.3 Asia Pacific Sodium Valproate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sodium Valproate Market Facts & Figures by Country
3.7.1 Latin America Sodium Valproate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sodium Valproate Sales by Country (2019-2030)
3.7.3 Latin America Sodium Valproate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sodium Valproate Market Facts & Figures by Country
3.8.1 Middle East and Africa Sodium Valproate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sodium Valproate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sodium Valproate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sodium Valproate Sales by Type (2019-2030)
4.1.1 Global Sodium Valproate Sales by Type (2019-2024)
4.1.2 Global Sodium Valproate Sales by Type (2025-2030)
4.1.3 Global Sodium Valproate Sales Market Share by Type (2019-2030)
4.2 Global Sodium Valproate Revenue by Type (2019-2030)
4.2.1 Global Sodium Valproate Revenue by Type (2019-2024)
4.2.2 Global Sodium Valproate Revenue by Type (2025-2030)
4.2.3 Global Sodium Valproate Revenue Market Share by Type (2019-2030)
4.3 Global Sodium Valproate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sodium Valproate Sales by Application (2019-2030)
5.1.1 Global Sodium Valproate Sales by Application (2019-2024)
5.1.2 Global Sodium Valproate Sales by Application (2025-2030)
5.1.3 Global Sodium Valproate Sales Market Share by Application (2019-2030)
5.2 Global Sodium Valproate Revenue by Application (2019-2030)
5.2.1 Global Sodium Valproate Revenue by Application (2019-2024)
5.2.2 Global Sodium Valproate Revenue by Application (2025-2030)
5.2.3 Global Sodium Valproate Revenue Market Share by Application (2019-2030)
5.3 Global Sodium Valproate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Sodium Valproate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Sodium Valproate Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Sodium Valproate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AbbVie Sodium Valproate Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Athenex
6.3.1 Athenex Corporation Information
6.3.2 Athenex Description and Business Overview
6.3.3 Athenex Sodium Valproate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Athenex Sodium Valproate Product Portfolio
6.3.5 Athenex Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Sodium Valproate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius Kabi Sodium Valproate Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Hikma Farmaceutica
6.5.1 Hikma Farmaceutica Corporation Information
6.5.2 Hikma Farmaceutica Description and Business Overview
6.5.3 Hikma Farmaceutica Sodium Valproate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hikma Farmaceutica Sodium Valproate Product Portfolio
6.5.5 Hikma Farmaceutica Recent Developments/Updates
6.6 Desitin Pharmaceuticals
6.6.1 Desitin Pharmaceuticals Corporation Information
6.6.2 Desitin Pharmaceuticals Description and Business Overview
6.6.3 Desitin Pharmaceuticals Sodium Valproate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Desitin Pharmaceuticals Sodium Valproate Product Portfolio
6.6.5 Desitin Pharmaceuticals Recent Developments/Updates
6.7 Wockhardt
6.6.1 Wockhardt Corporation Information
6.6.2 Wockhardt Description and Business Overview
6.6.3 Wockhardt Sodium Valproate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wockhardt Sodium Valproate Product Portfolio
6.7.5 Wockhardt Recent Developments/Updates
6.8 Zentiva
6.8.1 Zentiva Corporation Information
6.8.2 Zentiva Description and Business Overview
6.8.3 Zentiva Sodium Valproate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zentiva Sodium Valproate Product Portfolio
6.8.5 Zentiva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sodium Valproate Industry Chain Analysis
7.2 Sodium Valproate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sodium Valproate Production Mode & Process
7.4 Sodium Valproate Sales and Marketing
7.4.1 Sodium Valproate Sales Channels
7.4.2 Sodium Valproate Distributors
7.5 Sodium Valproate Customers
8 Sodium Valproate Market Dynamics
8.1 Sodium Valproate Industry Trends
8.2 Sodium Valproate Market Drivers
8.3 Sodium Valproate Market Challenges
8.4 Sodium Valproate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
